Commerce Bank’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $477K | Buy |
15,125
+100
| +0.7% | +$3.15K | ﹤0.01% | 875 |
|
|
2025
Q1 | $492K | Buy |
15,025
+1,720
| +13% | +$56.3K | ﹤0.01% | 850 |
|
|
2024
Q4 | $481K | Sell |
13,305
-225
| -2% | -$8.14K | ﹤0.01% | 873 |
|
|
2024
Q3 | $422K | Sell |
13,530
-305
| -2% | -$9.51K | ﹤0.01% | 949 |
|
|
2024
Q2 | $370K | Hold |
13,835
| – | – | ﹤0.01% | 955 |
|
|
2024
Q1 | $472K | Sell |
13,835
-510
| -4% | -$17.4K | ﹤0.01% | 881 |
|
|
2023
Q4 | $415K | Sell |
14,345
-172
| -1% | -$4.98K | ﹤0.01% | 909 |
|
|
2023
Q3 | $400K | Sell |
14,517
-208
| -1% | -$5.74K | ﹤0.01% | 857 |
|
|
2023
Q2 | $443K | Sell |
14,725
-175
| -1% | -$5.26K | ﹤0.01% | 840 |
|
|
2023
Q1 | $540K | Sell |
14,900
-575
| -4% | -$20.8K | ﹤0.01% | 774 |
|
|
2022
Q4 | $552K | Sell |
15,475
-4,235
| -21% | -$151K | ﹤0.01% | 751 |
|
|
2022
Q3 | $667K | Hold |
19,710
| – | – | 0.01% | 659 |
|
|
2022
Q2 | $570K | Hold |
19,710
| – | – | ﹤0.01% | 735 |
|
|
2022
Q1 | $637K | Sell |
19,710
-815
| -4% | -$26.3K | ﹤0.01% | 750 |
|
|
2021
Q4 | $598K | Buy |
20,525
+3,030
| +17% | +$88.3K | ﹤0.01% | 786 |
|
|
2021
Q3 | $466K | Sell |
17,495
-1,320
| -7% | -$35.2K | ﹤0.01% | 858 |
|
|
2021
Q2 | $579K | Sell |
18,815
-60
| -0.3% | -$1.85K | ﹤0.01% | 783 |
|
|
2021
Q1 | $494K | Buy |
18,875
+5,520
| +41% | +$144K | ﹤0.01% | 822 |
|
|
2020
Q4 | $336K | Sell |
13,355
-180
| -1% | -$4.53K | ﹤0.01% | 912 |
|
|
2020
Q3 | $282K | Buy |
13,535
+4,045
| +43% | +$84.3K | ﹤0.01% | 881 |
|
|
2020
Q2 | $225K | Buy |
+9,490
| New | +$225K | ﹤0.01% | 919 |
|